Diagnosis and monitoring of chronic viral hepatitis: Serologic and molecular markers

Frontiers in Bioscience - Scholar

Volumn 3 S, Issue 1, 2011, Pages 156-167

  Chakravarty, Runu ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Detection; HBV; HCV; HDV; Monitoring; Review

Indexed keywords

ADEFOVIR DIPIVOXIL; AMINOTRANSFERASE; DOUBLE STRANDED DNA; ENTECAVIR; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON; LAMIVUDINE; NEUTRALIZING ANTIBODY; TELBIVUDINE; TENOFOVIR; VIRUS DNA; ANTIVIRUS AGENT; BIOLOGICAL MARKER; VIRUS RNA;

AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL RESISTANCE; ARTICLE; CHRONIC HEPATITIS; CODON; DELTA AGENT HEPATITIS; DNA DETERMINATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MONITORING; NONHUMAN; PRACTICE GUIDELINE; SEROLOGY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS MUTANT; VIRUS REPLICATION; BLOOD; GENETICS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; ISOLATION AND PURIFICATION; METHODOLOGY; REVIEW; VIRUS HEPATITIS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; SATELLITE VIRUSES;

ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; MONITORING, PHYSIOLOGIC; RNA, VIRAL;

EID: 79955960799     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s141     Document Type: Article

References (83)

1. D. Lavanchy: Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11, 97-107 (2004) (Pubitemid 38365759)
2. C.W. Shepard, L. Finelli, M.J. Alter: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567 (2005) (Pubitemid 41196755)
3. D.M. Parkin: The global health burden of infectionassociated cancers in the year 2002. Int J Cancer 118, 3030-3044 (2006)
4. D Ganem, RJ Schneider, Fields Virology- Hepadnaviridae: the viruses and their replication. Philadelphia: Lippincott Williams &Wilkins (2001)
5. S. Schaefer: Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 13, 14-21 (2007) (Pubitemid 46165459)
6. C.J. Chu, AS Lok: Clinical significance of hepatitis B virus genotypes. Hepatology 35, 1274- 1 276 (2002) (Pubitemid 34454026)
7. S.K. Fung, ASF Lok: Hepatitis B Virus Genotypes: Do They Play a Role inthe Outcome of HBV Infection? Hepatology 40, 790-792 (2004) (Pubitemid 39288110)
8. B.J. McMahon, W.L. Alward, D.B. Hall: Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151,599-603 (1985) (Pubitemid 15102154)
9. S.F. Lok: Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43, S173-S181 (2005)
10. G.B. Schreiber, M.P. Busch, S.H. Kleinman, J.J Korelitz: The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 334, 1685-1690 (1996) (Pubitemid 26193619)
11. C.K. Hui, W.W.Cheung, H.Y. Zhang, W.Y. Au, Y.H. Yueng, A.Y. Leung, N. Leung, J.M. Luk, A.K. Lie, Y.L. Kwong, R. Liang, G.K. Lau: Kinetics and risk of de novo hepatitis B infection in HBs Ag-negative patients undergoing cytotoxic chemotherapy. Gastroenterology 131,59-68 (2006) (Pubitemid 44015749)
12. A.J. Chamorro, J.L. Casado, D. Bellido, S. Moreno: Reactivation of hepatitis B in an HIV-infected pati ent with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis 24: 492-494 (2005) (Pubitemid 41124504)
13. T. Pollicino, G. Squadrito, G. Cerenzia, I. Cacciola, G. Raffa, A. Craxi, F. Farinati, G. Missale, A. Smedile, C. Tiribelli, E.Villa, G. Raimondo: Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 126,102-110 (2004) (Pubitemid 38040728)
14. K. Ikeda, H. Marusawa, Y. Osaki, T. Nakamura, N. Kitajima, Y. Yamashita, M. Kudo, T. Sato, T. Chibal: Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: A prospective study. Ann Intern Med 146,649-656 (2007) (Pubitemid 351650520)
15. C. Brechot, V. Thiers, D. Kremsdorf, B. Nalpas, S. Pol, and P. Paterlini-Brechot: Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult "? Hepatology 34,194-203 (2001) (Pubitemid 32591500)
16. A. Banerjee, P.K. Chandra, S. Datta, A. Biswas, P. Bhattacharya, S. Chakrab arti, S.K. Bhattacharya, R. Chakravarty: Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only ' individuals in Eastern India. J Clin Virol 40, 312-317 (2007) (Pubitemid 350151995)
17. M. Torbenson, and D. L. Thomas: Occult hepatitis B. Lancet Infect.Dis 2, 479-486 (2002) (Pubitemid 34826853)
18. R.T. Horvat, and G. E. Tegtmeier, Manual of clinical microbiology: Hepatitis B and D viruses. ASM Press, Washington, DC.
19. B. Weber: Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol 32, 102-112 (2005) (Pubitemid 40093960)
20. S. Datta, A. Biswas, P.K. Chandra, A. Banerjee, R. Panigrahi, P.K. Mahapatra, S. Chakrabarti, C.K. Panda, R. Chakravarty: Molecular epidemiology and clinical significance of hepatitis B virus genotypes, core promoter and pre-core mutations in eastern India. Intervirology 51, 275-84 (2008)
21. A.S. Lok, E.J. Heathcote & J.H. Hoofnagle: Management of hepatitis B: 2000-summary of a workshop.Gastroenterology 120, 1828-1853 (2001)
22. R.G. Gish: Diagnosis of chronic hepatitis B and the implications of viral variants and mutations. Am J Med 12, S12-21 (2008)
23. F. Kurbanov, Y. Tanaka, M. Mizokami: Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res 40, 14- 30 (2010)
24. C.J. Liu, JH Kao: Genetic variability of hepatitis B virus and response to antiviral therapy. Antivir Ther 13, 613-24 (2008)
25. C.J. Liu, J.H. Kao, D.S. Chen: Therapeutic implications of hepatitis B genotypes. Liver Int 25, 1097-1107 (2005)
26. R.Y. Sertoz, S. Erensoy, S. Pas, U.S. Akarca, F. Ozgenc, T. Yamazhan, T. Ozacar, H.G.Niesters: Comparison of sequence analysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. J Chemother 17, 514-520 (2005) (Pubitemid 41699715)
27. W. Chotiyaputta and A.S.F. Lok: Hepatitis B virus variants. Nat Rev Gastroenterol Hepatol 6, 453-62 (2009)
28. R.H. Gish, S.A. Locarnini: Chronic hepatitis B current testing strategies. Clin Gastroenterol Hepatol. 2006 Jun;4 (6):666-76. (Pubitemid 43825809)
29. M. Hussain, C.J. Chu, E. Sablon & A.S. Lok: Rapid and sensitive assays for determination of hepatitis B virus (HBV) genotypes and detection of HBV precore and core promoter variants. J Clin Microbiol 41,3699-3705 (2003) (Pubitemid 36994704)
30. D.K. Wong, M.F. Yuen, V.W. Ngai, J. Fung, C.L. Lai: One-year entecavir or lamivudine therapy results in reduction of hepatitis B virus intrahepatic covalently closed circular DNA levels. Antivir Ther 11, 909-16 (2006) (Pubitemid 44736182)
31. A. S. F. Lok and B. J. McMahon. Chronic Hepatitis B: AASLD Practice Guidelines. Hepatology 45, 507-39 (2007)
32. J.H. Kao: Appropriate use of interferon for use of chronic hepatitis B. Hepatol Res. 2007 Jul;37 (s1):S47-S54.
33. J.M. Pawlotsky, G.. Dusheiko, A. Hatzakis, D. Lau ,G. Lau , T.J. Liang, S. Locarnini, P. Martin, D.D. Richman, F. Zoulim: Virologic monitoring of hepatitis B virus therapy in clinical trials and practice: recommendations for a standardized approach. Gastroenterology 134, 405-415 (2008) (Pubitemid 351181309)
34. C.L. Lai & M.F. Yuen: The n atural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med. 2007 Jul 3;147 (1):58-61. ()
35. A.S. Lok, B.J. McMahon: Chronic hepatitis B: update 2009. Hepatology 50, 661-2 (2009)
36. E. Libbrecht, J. Doutreloigne, H. Van De Veldel, M.F. Yuen, C.L. Lai, F. Shapiro, E. Sablon: Evolution of primary and co mpensatory lamivudine resistance mutations in chronic hepatitis B virus-infected patients during longterm lamivudine treatment, assessed by a line probe assay. J Clin Microbiol 45, 3935-3941 (2007) (Pubitemid 350274873)
37. C. Osiowy, J.P. Villeneuve, E.J. Heathcote, E. Giles, J. Borlang: Detection of rtN236Tand rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HB V DR line probe assay (version 2) J Clin Microbiol 44, 1994-1997 (2006) (Pubitemid 43902144)
38. V. Soriano, M. Puoti, M. Peters, Y. Benhamou, M. Sulkowski, f. Zoulim, S. Mauss, J. Rockstroh: Care of patients with chronic hepatitis B and HIV coinfection: Recommendations from an international HBV/HIV panel. AIDS. 31;22 (12):1399-410 (2008)
39. J. Sheldon, N. Camino, B. Rodes, A. Bartholomeusz, M. Kuiper, F. Tacke, M. Núñez , S. Mauss, T. Lutz, G. Klausen, S. Locarnini, V. Soriano: Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir. Antivir Ther 10,727-734 (2005) (Pubitemid 41376852)
40. C.W. Shepard, L. Finelli , M.J. Alter: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567 (2005) (Pubitemid 41196755)
41. C.F. Kwiatkowski, K. Fortuin Corsi, R.E. Booth: The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 97,1289-1294 (2002)
42. S. Chevaliez and J.M. Pawlotsky: HCV genome and life cycle: Tan S-L Ed Hepatitis C viruses: genome and molecular biology. Horizon Bioscience 5-47 (2006)
43. S Chevaliez and JM Pawlotsky: Hepatitis C virus: Virology, diagnosis and management of antiviral therapy. World J Gastroenterol 13, 2461-2466 (2007) (Pubitemid 46929502)
44. National Institutes of Health: National Institutes of Health Consensus Development Conference Statement: management of he patitis C: June 10-12, 2002. Hepatology 36 (suppl 1), S3-S20 (2002)
45. M.J Alter, H.S Margolis, K. Krawczynski, A.Mares, W.J.Alexander, P.Y.Hun, J.K. Miller, M.A. Gerber and R.E. Sampliner: The natural history of community-acquired hepatitis C in the United States: the Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 327, 1899-1905 (1992) (Pubitemid 23006964)
46. G.M. Lauer, B.D. Walker: Hepatitis C virus infection. N Engl J Med 345,41-52 (2001) (Pubitemid 32634271)
47. M.G. Bruce, D. Bruden, B.J. McMahon, C. Christensen, C. Homan, D. Sullivan, H. Deubner, T. Hennessy, J. Williams, S. Livingston and D. Gretch: Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated, or fluctuating alanine aminotransferase levels. Liver Int 26, 643-649 (2006) (Pubitemid 43983880)
48. E. Sagnelli, N. Coppola, C. and Marrocco: Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation. J Biol Regul Homeost Agents 17, 207-210 (2003) (Pubitemid 37220858)
49. E. Sagnelli, N. Coppola, C. Marrocco Coviello G, M. Battaglia, V. Messina, G. Rossi, C. Sagnelli, C. Scolastico, P. Filippini: Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 42, 646-651 (2005)
50. M. Letowska, E. Brojer, M. Mikulska, A. Gronowska, A. Rosiek: Hepatitis C core antigen in Polish blood donors. Transfusion 44,1067-71 (2004) (Pubitemid 38828282)
51. C. Sanz, D.Tassies, J. Costa, C Freire, A. Pereira: The first case of HCV infection detected before seroconversion in blood donors tested by HCV core antigen ELISA. Transfusion 42,505-6 (2002)
52. R. Soffredini, M.G. Rumi, M.L. Parravicini, G. Ronchi, E.Del Ninno, A.Russo, M Colombo: Serum levels of hepatitis C virus core antigen as a marker of infection and respo nse to therapy. Am J Gastroenterol 99:1738-43 (2004) (Pubitemid 39237502)
53. K. Seme, M. Poljak, D. Z. Babič, T. Močilnik, A. Vince: The role of core antigen detection in management of hepatitis C: a critical review. J Clin Virol 32, 92-101 (2005) (Pubitemid 40093959)
54. M. Houghton, Fields Virology-Hepatitis C viruses. Philadelphia : Lippincott-Raven Publishers, (1996)
55. E.R. Schiff, M. Medina, R.S. Kahn: New perspectives in the diagnosis of hepatitis C. Semin Liver Dis. 19 Suppl 1:3-15 (1999)
56. D.R. Gretch: Diagnostic tests for hepatitis C. Hepatology 26 (suppl 1), 43S-47S. (1997) (Pubitemid 27388071)
57. A. Ferreira-Gonzalez, M.L. Shiffman: Use of diagnostic testing for managing hepatitis C virus infection. Semin Liver Dis 24: 9-18 (2004) (Pubitemid 39180701)
58. J.M. Pawlotsky: Molecular diagnosis of viral hepatitis. Gastroenterology 122 (6):1554-68. (2002)
59. M. Martell, J. Gomez, J.I. Esteban, S. Sauleda, J. Quer, B. Cabot, R. Esteban, J. Guardia: High-throughput realtime reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 37 (2), 327-332 (1999) (Pubitemid 29056398)
60. F. Komurian-Pradel, G. Paranhos-Baccala, M. Sodoyer, P. Chevallier, B. Mandrand, V. Lotteau, P. Andre: Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 95, 111-119 (2001) (Pubitemid 32493842)
61. S. Chevaliez, M. Bouvier-Alias, R. Brillet, J.M. Pawlotsky: Overestimation and underestimation of hepatitis C virus RNA levels with real-time polymerase chain reaction. Hepatology 46 (1), 22-31 (2007) (Pubitemid 47171917)
62. M.P. Manns, J.G. McHutchison, S.C. Gordon, V.K. Rustgi, M. Shiffman , R. Reindollar, Z.D.Goodman, K. Koury, M. Ling, J.K. Albrecht: Peginterfer on alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358,958-965 (2001) (Pubitemid 32913521)
63. S.J. Hadziyannis, H. Sette Jr, T.R. Morgan, V. Balan, M. Diago, P. Marcellin, G. Ramadori, H. Jr Bodenheimer, D.Bernstein, M. Rizzetto, S. Zeuzem , P.J. Pockros, A. Lin, A.M. Ackrill : Peginterferon-alpha2a and ribavirin combination therapy in c hronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med; 140 (5):346-55 (2004)
64. S. Feinstone, P. Halfon, G. Inchauspe, C. Kuiken, G. Maertens, M. Mizo kami, D.G. Murphy, H. Okamoto, J.H. Pawlotsky, F. Penin, E. Sablon, T. Shin-I, L.J. Stuyver , H.J. Thiel, S.Viazov, A.J. Weiner, A. Widell: Consensus proposals for a unified system of nomenclature of hepati tis C virus genotypes. Hepatology 42, 962-973 (2005) (Pubitemid 41401136)
65. R.Y. Sertoz, S. Erensoy, S. Pas, U.S. Akarca, F. Ozgenc, T. Yamazhan, T. Ozacar, H.G. Niesters: Comparison of sequence anal ysis and INNO-LiPA HBV DR line probe assay in patients with chronic hepatitis B. J Chemother 17, 514-520 (2005) (Pubitemid 41699715)
66. J.M. Pawlotsky, L. Prescott, P. Simmonds, C. Pellet, P. Laurent-Puig, C. Lab onne, F. Darthuy, J. Remire, J. Duval J, C. Buffet, J.P.Etienne, D. Dhumeaux , E. Dussaix: Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay. J Clin Microbiol 35, 1734-1739 (1997) (Pubitemid 27255649)
67. M. Kurosaki, N. Enomoto, F. Marumo, C. Sato: Evolution and selection of hepatitis C virus in patients with chronic hepatitis C. Virology205,161-169 (1994) (Pubitemid 24360602)
68. N. Enomoto, M. Kurosaki, Y. Tanaka, F. Marumo, C. Sato: Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol,1361-9 (1994) (Pubitemid 24174051)
69. S. Okada, Y. Akahane, H. Suzuki, H. Okamoto, S. Mishiro: The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates wit h responsiveness to interferon therapy in viremic patients. Hepatology 16, 619-624 (1992)
70. M.T. Komman, G. Leparc, K. Benson: Pathology update-nucleic acid amplification testing: the new infectious diseaes testing method for donor blood. Cancer Control JMCC 6,504-508 (1999) (Pubitemid 29508296)
71. A.S. Lok, D. Chien, Q.L. Choo, T.M. Chan , E.K. Chiu , I.K. Cheng, M. Houghton, G. Kuol: Antibody response to core, envelope and nonstructural hepatitis C virus antigens: comparison of immunocompetent and immunosuppressed patients. Hepatology 18, 497-502 (1993) (Pubitemid 23259946)
72. C.L. Thio, K.R. Nolt, J. Astemborski, D. Vlahov, K.E. Nelson, D.L. Thomas: Screening for hepatitis C virus in human immunodeficiency vi rus-infected individuals. J Clin Microbiol 38, 575-7 (2000) (Pubitemid 30082644)
73. M. M. C. Lai: The molecular biology of hepatitis delta virus. Annual Review of Biochemistry 64, 259-286 (1995)
74. S. Makino, M.F. Chang, C.K. Shieh, T. Kamahora, D.M. Vannier, S. Govindarajan, M.M. Lai: Molecular cloning and sequencing of a human hepatitis delta (?) virus RNA. Nature 329, 343-346 (1987) (Pubitemid 17134359)
75. R.A. Collins: Hepatitis D: The parasite's parasite. THE BIOMEDICAL SCIENTIST, 1-5 (2005)
76. S. J. Hadziyannis: Review: hepatitis delta. J Gastroenterol Hepatol. 12, 289-298 (1997)
77. H. Wedemeyer and M. P. Manns: Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat. Rev. Gastroenterol. Hepatol. 7, 31- 40 (2010)
78. H. Wedemeyer, B. Heidrich and M. P. Manns: Hepatitis D virus infection-not a vanishing disease in Europe. Hepatology 45, 1331-1332 (2007) (Pubitemid 46775802)
79. A. Kos, R. Dijkema, A. C. Arnberg, P. H. van derMeide, and H. Schellekens: The hepatitis delta (δ) virus possesses a circular RNA. Nature 323, 558-560 (1986) (Pubitemid 16025382)
80. E. Lehmann, F. Brueckner, and P. Cramer: Molecular basis of RNA-dependent RNA polymerase II activity. Nature 450, 445-449 (2007) (Pubitemid 350126752)
81. P.J. Chen, G. Kalpana, J. Goldberg: Structure and replication of the genome of the hepatitis δ virus. Proceedings of the National Academy of Sciences of the United States of America 83, 8774-8778 (1986) (Pubitemid 17194948)
82. I. Mederacke, B. Bremer, B. Heidrich, J. Kirschner, K. Deterding, T. Bock, K. Wursthorn, M.P. Manns, H. Wedemeyer. Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 48 (6),2022-9 (2010)
83. K. Zachou, C. Yurdaydin, U. Drebber, G.N. Dalekos, A. Erhardt, Y. Cakaloglu, H. Degertekin, S. Gurel, S. Zeuzem, H. Bozkaya, V. Schlaphoff, H.P. Dienes, T.C. Bock, M.P. Manns, H. Wedemeyer. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int 30 (3):430-7 (2010)